PSMA-D5

CAT:
804-HY-P10781-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
PSMA-D5 - image 1

PSMA-D5

  • Description :

    PSMA-D5 has a binding affinity for PSMA with Ki of 0.21 nM and can be used for PSMA tracing after radiolabeling. PSMA-D5 ([68Ga]-labeled) contains a DOTA chelator, allowing convenient labeling with therapeutic radionuclides such as 177Lu and 225Ac. PSMA-D5 ([68Ga]-labeled) shows excellent pharmacokinetic properties, exhibiting remarkable tumor uptake in 22Rv1 tumors[1]. PSMA-D5 can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) .
  • CAS Number :

    [3056440-83-3]
  • UNSPSC :

    12352209
  • Target :

    PSMA; Radionuclide-Drug Conjugates (RDCs)
  • Related Pathways :

    Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
  • Applications :

    Cancer-programmed cell death
  • Field of Research :

    Cancer
  • Purity :

    98.61
  • Solubility :

    DMSO : 50 mg/mL (ultrasonic)
  • Smiles :

    OC([C@@H](NC(N[C@H](C(O)=O)CCC(O)=O)=O)CCCCNC(C1=CC(C2=CC=C(C=C2)NC(CCNC(CN3CCN(CCN(CCN(CC3)CC(O)=O)CC(O)=O)CC(O)=O)=O)=O)=CC(C(NCCCC[C@H](NC(N[C@@H](CCC(O)=O)C(O)=O)=O)C(O)=O)=O)=C1)=O)=O
  • Molecular Formula :

    C57H80N12O24
  • Molecular Weight :

    1317.31
  • References & Citations :

    [1]Chen Y, et al. Synthesis, Preclinical Evaluation, and First-in-Human PET Study of [68Ga]-Labeled Biphenyl-Containing PSMA Tracers. J Med Chem. 2023 Sep 28;66 (18) :13332-13345.
  • Shipping Conditions :

    Blue Ice
  • Storage Conditions :

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
  • Scientific Category :

    Peptides
  • Clinical Information :

    No Development Reported

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide